Zymeworks
Tracked across 2 events · 12 articles · First seen Jul 16, 2026 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Zymeworks is the subject of the announcement; it will report Q2 results and skip the earnings call due to the pending acquisition of Theravance Biopharma.
Jul 16, 2026 · 6 articles
Business
Zymeworks Inc., a biotechnology company, announced that its management will participate in several upcoming investor conferences in September 2026. These include the Wells Fargo Healthcare Conference on September 8 in Boston, Citi's Biopharma Back to…
Impact: Zymeworks is the subject of the announcement, participating in investor conferences to engage with the investment community. This is a routine corporate activity with minimal direct impact on its valuation.
Aug 11, 2026 · 6 articles
10
Zymeworks announced financial results dateZymeworks investor...
ERGEN INTELLIGENCE
Track Zymeworks live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard